Publications 2007

Abgrall S, Yeni PG, Bouchaud O, Costagliola D, Clinical Epidemiology Group of the French Hospital Database on HIV. Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir. Clin Infect Dis. 1 janv 2007;44(1):120‑7. Disponible sur:

Antiretroviral Therapy Cohort Collaboration. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients. J Acquir Immune Defic Syndr. 15 déc 2007;46(5):607‑15. Disponible sur:

Antiretroviral Therapy in Low-Income Countries Collaboration of the International epidemiological Databases to Evaluate AIDS (IeDEA), ART Cohort Collaboration, Brinkhof MWG, Egger M, Boulle A, May M, et al. Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clin Infect Dis. 1 déc 2007;45(11):1518‑21. Disponible sur:

Guiguet M, Furco A, Tattevin P, Costagliola D, Molina J-M, French Hospital Database on HIV Clinical Epidemiology Group. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV. HIV Med. mars 2007;8(2):124‑30. Disponible sur:

Lanoy E, Mary-Krause M, Tattevin P, Perbost I, Poizot-Martin I, Dupont C, et al. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther. 2007;12(1):89‑96. Disponible sur:

May M, Sterne JAC, Sabin C, Costagliola D, Justice AC, Thiébaut R, et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS. 31 mai 2007;21(9):1185‑97. Disponible sur:

Potard V, Rey D, Mokhtari S, Frixon-Marin V, Pradier C, Rozenbaum W, et al. First-line highly active antiretroviral regimens in 2001-2002 in the French Hospital Database on HIV: combination prescribed and biological outcomes. Antivir Ther. 2007;12(3):317‑24. Disponible sur: